Literature DB >> 21932482

Justifying research risks in a clinical trial for treatment of multidrug-resistant tuberculosis.

Charles M Heilig1, David Chia, Wafaa M El-Sadr, Yael Hirsch-Moverman, William R Mac Kenzie, Jussi Saukkonen, Margarita E Villarino, Nesri Padayatchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21932482

Source DB:  PubMed          Journal:  IRB        ISSN： 0193-7758


× No keyword cloud information.
  2 in total

1.  Who is the research subject in cluster randomized trials in health research?

Authors:  Andrew D McRae; Charles Weijer; Ariella Binik; Angela White; Jeremy M Grimshaw; Robert Boruch; Jamie C Brehaut; Allan Donner; Martin P Eccles; Raphael Saginur; Merrick Zwarenstein; Monica Taljaard
Journal:  Trials       Date:  2011-07-26       Impact factor: 2.279

2.  Optimizing the protection of research participants and personnel in HIV-related research where TB is prevalent: practical solutions for improving infection control.

Authors:  Jason E Farley; Timothy F Landers; Catherine Godfrey; Virginia Lipke; Jeremy Sugarman
Journal:  J Acquir Immune Defic Syndr       Date:  2014-01-01       Impact factor: 3.731
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.